- Intuitive Surgical (ISRG, Financial) reported strong Q1 2025 results with 19% revenue growth to $2.25 billion.
- GAAP net income increased by 28% to $698 million, or $1.92 per diluted share.
- The da Vinci surgical system installations rose 17% to 367 units, including 147 da Vinci 5 systems.
Intuitive Surgical (ISRG) announced robust financial performance for the first quarter of 2025, achieving a revenue of $2.25 billion, reflecting a 19% increase from the previous year's $1.89 billion. This growth was primarily driven by a 17% rise in da Vinci procedure volumes and significant adoption of their new da Vinci 5 system.
The number of da Vinci surgical systems installed in Q1 2025 reached 367, compared to 313 systems during the same period in 2024. Notably, 147 of these were the newly launched da Vinci 5 systems, compared to just 8 units installed in Q1 2024, indicating robust market acceptance.
Intuitive's total installed base of da Vinci systems expanded by 15% year-over-year to 10,189 systems, providing a solid foundation for future recurring revenue through instruments and accessories, which saw an 18% revenue increase to $1.37 billion.
GAAP net income surged to $698 million ($1.92 per diluted share) from $545 million ($1.51 per diluted share) in Q1 2024. The non-GAAP net income also improved, reaching $662 million ($1.81 per diluted share) up from $541 million ($1.50 per diluted share) YoY.
Looking forward, Intuitive projects a continued global da Vinci procedure growth of 15-17% for the full year of 2025. However, the company forecasts a decline in its non-GAAP gross profit margin to a range of 65-66.5%, impacted by potential tariffs on operations in China.
Intuitive concluded Q1 2025 with a strong cash and investments position of $9.10 billion, up $269 million from the previous quarter, ensuring ample resources for future growth and investments. The increase was primarily driven by operating cash flows.
